Background: Daily variability of heart rate in 24-h Holter recordings in dogs with atrial fibrillation (AF) receiving antiarrhythmic drugs (AAD) is unknown and could influence medical decisions.
Hypothesis/objectives: Dogs with AF, Holter-derived mean heart rate (meanHRHolter) over 24 h is not significantly different from a subsequent, consecutive 24-h period.
Animals: Twenty-five dogs with AF.
Methods: Prospective, descriptive, multicenter study. MeanHRHolter rate and ventricular arrhythmias (VAs) were prospectively analyzed after starting AAD. Clinically relevant difference (defined as ≥ 10 bpm in the meanHRHolter), success of rate control (defined as meanHRHolter ≤ 125 bpm). A Bland-Altman analysis and intra-class correlation coefficient (ICC) were calculated to compare two consecutive 24-h Holter recordings. VAs percentage difference [(maximum daily value-minimum daily value)/maximum daily value × 100] and grading variability between recordings were also investigated.
Results: Small BIAS with ICC 0.98 (95% confidence interval [CI] 0.95-0.99) on meanHRHolter with no statistical difference between two consecutive 24-h Holter recordings (95% CI [-2.84-2.92], degree of freedom 24, p = 0.98). Only 2/25 dogs (8%; 95% CI [2%-25%]) had clinically significant variation, while 1/25 (4%; 95% CI [0%-20%]) dogs showed different classifications in the success of rate control between the consecutive recordings. The VAs percentage difference was 52%, with 7/25 (28%; 95% CI [14%-47%]) dogs showing a VAs grading difference of ≥ 2.
Conclusion And Clinical Importance: The daily heart rate variability in dogs with AF receiving AAD is low, suggesting that a single 24-h Holter recording is adequate to assess rate control. Daily variability might be an important consideration when assessing VAs in dogs with concomitant AF.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1111/jvim.70051 | DOI Listing |
Geriatr Gerontol Int
March 2025
Department of Clinical Pharmacology and Therapeutics, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan.
Aim: Rehospitalization of patients with heart failure (HF) incurs high health care costs and increased mortality. Infection-related rehospitalizations in patients with HF occur frequently, and the risk increases with age. This study aimed to identify the factors associated with infection-related rehospitalizations in older patients with HF.
View Article and Find Full Text PDFNutr Hosp
March 2025
Facultad de Salud. Universidad Autónoma de Manizales.
Front Behav Neurosci
February 2025
Department of Cognitive Science, University of California, Irvine, CA, United States.
Emotional memories change over time, but the mechanisms supporting this change are not well understood. Sleep has been identified as one mechanism that supports memory consolidation, with sleep selectively benefitting negative emotional consolidation at the expense of neutral memories, with specific oscillatory events linked to this process. In contrast, the consolidation of neutral and positive memories, compared to negative memories, has been associated with increased vagally mediated heart rate variability (HRV) during wakefulness.
View Article and Find Full Text PDFFront Cardiovasc Med
February 2025
The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, Suzhou, Jiangsu, China.
Objective: Estimated glucose disposal rate (eGDR) is a reliable marker of insulin resistance (IR), which has been proven to be strongly linked to cardiovascular and renal diseases. However, the link between eGDR and the occurrence of cardiovascular disease (CVD) in individuals exhibiting Cardiovascular-Kidney-Metabolic (CKM) syndrome stages 0-3 remains ambiguous.
Methods: The data employed in this investigation was procured from the China Health and Retirement Longitudinal Study (CHARLS).
Circ Rep
March 2025
Division of Cardiovascular Medicine, Department of Medicine, Jichi Medical University School of Medicine Tochigi Japan.
Background: Studies have shown an increased risk of cardiovascular events during treatment with febuxostat vs. allopurinol, but comparative data with another xanthine oxidoreductase inhibitor (XORi), topiroxostat, are lacking. In this retrospective study we compared the incidence of cardiovascular/renal events in Japanese patients with newly diagnosed hyperuricemia and/or gout treated with allopurinol, febuxostat or topiroxostat.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!